Preventing airborne aspergillosis infection reaching immunocompromised transplant patients is a difficult task. Hospital heating and ventilation systems are expensive, disruptive and time-consuming to modify to deliver Airborne Infection Isolation (AII) areas within a healthcare setting. With the potential for releasing aspergillus spores during any building works, a stand-alone solution must be preferable.
The highly effective, inexpensive and easily deployed solution against invasive aspergillosis infection from Commercial Air Filtration is to create a locally controlled environment for each individual room in a transplant unit with susceptive patients. Mobile IQAir units can be deployed directly at each critical location to capture and retain bacteria, viruses and mould spores, as well as bioaerosols without any need for building, works. This local solution works in tandem with your existing hospital ventilation system in its fight against invasive aspergillosis infection.
With invasive aspergillosis affecting 25% of both allogeneic bone marrow transplant cases and a similar amount of acute leukaemia patients, this is highly effective prevention against infection.